
Laetitia G. GarciaUniversité Catholique de Louvain - UCLouvain | UCLouvain · Louvain Drug Research Institute (LDRI)
Laetitia G. Garcia
PhD in Biomedical & Pharmaceutical Sciences
About
3
Publications
708
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
187
Citations
Publications
Publications (3)
The pathogen Staphylococcus aureus uses various strategies for persisting in the host, among which switching to a small-colony variant (SCV) phenotype is of particular biological and therapeutic significance. Phenotypically, SCVs are characterized by a slow growth rate, atypical colony morphology and unusual biochemical features, constituting a rea...
Background:
Ceftaroline fosamil is approved for treatment of acute bacterial skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus (MRSA). We examined the activity of its active metabolite (ceftaroline) against intracellular forms of S. aureus in comparison with vancomycin, daptomycin and linezolid.
Methods:
Tw...
In a previous paper (Garcia et al, 2012, 56 (7): 3700-3711), we studied the intracellular fate of menD and hemB mutants (corresponding to menadione- and hemin-dependent SCVs, respectively) of the parental COL MRSA strain and the pharmacodynamic profile of intracellular activity of a series of antibiotics in human THP-1 monocytes. We have now examin...